Canada · Health Canada Drug Product Database
BAT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 94692
- DIN
- 02459612
- Form
- Solution
- Company as listed by source
- EMERGENT BIOSOLUTIONS CANADA INC.
- Source status
- Restricted Access (2017-10-25)
- Source last updated
- 2025-11-28
Source-listed ingredients
- BOTULINUM ANTITOXIN SEROTYPE A — 4500 UNIT — per 1 VIAL
- BOTULINUM ANTITOXIN SEROTYPE B — 3300 UNIT — per 1 VIAL
- BOTULINUM ANTITOXIN SEROTYPE C — 3000 UNIT — per 1 VIAL
- BOTULINUM ANTITOXIN SEROTYPE D — 600 UNIT — per 1 VIAL
- BOTULINUM ANTITOXIN SEROTYPE E — 5100 UNIT — per 1 VIAL
- BOTULINUM ANTITOXIN SEROTYPE F — 3000 UNIT — per 1 VIAL
- BOTULINUM ANTITOXIN SEROTYPE G — 600 UNIT — per 1 VIAL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 To 22 Ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →